OralCDx Email Format
Hospitals and Health CareNew York, United States2-10 Employees
OralCDx develops a brush-based testing tool designed to screen for precancerous cells in oral lesions. By analyzing common white or red spots in the mouth, the product aims to identify potential precursors to oral cancer, enabling early intervention before progression. The company positions itself within the health care sector focused on cancer prevention, serving clinicians who treat patients across primary care, dental, and related specialties. Based in Suffern, New York, the organization operates with a small team and maintains a presence in the U.S. market through its product offering. The broader context of oral cancer emphasizes rising incidence and links to factors beyond tobacco or alcohol use, underscoring the potential value of early detection tools like OralCDx in routine examination settings.